Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-06-20

Clinical Trial Update: Study to Assess the Effectiveness of a Omega-3 Enriched Supplement on Chemotherapy Tolerance in Colon Cancer Patients [Phase 4]

View source ↗

Summary

Phase 4 trial assessing whether an omega-3 enriched supplement improves chemotherapy tolerance in colorectal cancer (colon cancer) patients. The study was termi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Omega-3 enriched supplement (omega-3 fatty acids supplement)

Snippet

Sponsor: Hospital Clinic of Barcelona | Conditions: Colorectal Neoplasms | Phase 4 | Status: TERMINATED